Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 40%Low 3 · 60%Moderate 0 · 0%High 0 · 0%

Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease

5‐ASA may leads to lower withdrawal due to adverse events compared with purine antimetabolites (low certainty).

1 finding from 1 review

Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease

It is very uncertain whether 5‐ASA changes withdrawal due to adverse events compared with no treatment (very low certainty).

1 finding from 1 review

Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease

5‐ASAs showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease

It is very uncertain whether 5‐ASAs changes withdrawal due to adverse events compared with anti TNF‐ɑ (very low certainty).

1 finding from 1 review

Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease

High dose 5‐ASA showed no clear difference in withdrawal due to adverse events compared with low dose 5‐ASA (low certainty).

1 finding from 1 review